Start A Thread

Rate Intersect ENT

  • Culture

  • Compensation

  • Opportunity for advancement

  • Realistic plan attainment

×

Salaries

In our drive to help people in the medical sales industry we are gathering salary data. This information will be collated, analyzed and number crunched. Medtechy’s overall goal is to help the medical sales industry make more informed decisions when changing jobs and also keep employers and recruiters honest

Take 30 seconds and let us know your current deal.*

About The Position

Compensation

* We guarantee all data collected is completely anonymous and will only be used for the benefit of future visitors.

×

Hot Ticker Articles

What's Next for TransEnterix after Senhance's FDA Clearance

Business Travel Tip: Watch your home TV with a streaming stick

Depuy Attune objection handling presentation and the new Attune S+ technology

Apple one of 9 companies chosen for FDA pilot program and what it means for the revolution in digital healthcare

Titan Medical Announces First Procedures with SPORT Surgical System

Highlights from Nevro's Presentation at the Morgan Stanley 2017 Global Healthcare Conference

TransEnterix is one step closer to FDA approval for Senhance

Did Medtronic accidentally release the name of their robotic surgery program?

Can TransEnterix overtake Intuitive Surgical in the robotic surgery race?

Boost sales with a simple 7 step pre-call plan

4 Tips for Managing a New Medical Sales Territory

Job Listings

Arrinex

17 hours ago

I think this is where DS went. Do not know anything else about them.

Good Company to work for? Good Territory?

1 week ago

Is the 170k to 210k that I was told by a recruiter accurate? And no nonsense - the good, bad and ugly of the job and working at IntersectENT?


Keep Stocking Those Shelves Intersect ENT

2 months ago

Intersect paid him like 75 grand last year. Of course he does a lot of business with them.


Intersect ENT Earnings $XENT

3 months ago

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the second quarter ended June 30, 2017.

Second Quarter Financial Highlights

  • Second quarter 2017 revenue was $24.0 million, a 24% increase over the second quarter 2016
  • Second quarter 2017 gross margin was 85% compared to 84% in the second quarter 2016

Second Quarter Business Highlights

  • The …

All is great

3 months ago

All the ENT companies are in disarray except Intersect. What's in the water over there?


Intersect ENT Insider Selling Part Deux

4 months ago

Face it, Lisa has more shares than she knows what to do with. Ask why they aren't a greater part of your compensation.They will laugh. You should then understand what the E team thinks of the reps. Replaceable.



Loading...